Сравнение

Icatibant vs. Nafarelin

Два пептида рядом — идентичность, доказательная база, правовой статус и известные нежелательные явления.

Идентичность

Категория

Исследования (прочее)

Номер CAS

138614-30-9

нет данных

Молекулярная масса

1304.52 g/mol

нет данных

Период полувыведения

нет данных

Последовательность

нет данных

Механизм действия

Icatibant

Icatibant competitively blocks the bradykinin B2 receptor. Because bradykinin mediates the vascular permeability, swelling and pain typical of hereditary angioedema, the blockade interrupts the acute attack.

Nafarelin

Nafarelin is a potent GnRH agonist: after an initial stimulation ('flare'), continuous receptor occupancy leads to downregulation and thereby suppression of LH, FSH and the downstream sex hormones.

Доказательная база

Наивысшая доказательность

РКИ на людях

Исследования

из них на людях

Зафиксированные эффекты

Открытые противоречия

Задокументированные нежелательные явления

Правовой статус

Country	Icatibant	Nafarelin
Германия	Рецептурный	Рецептурный
США	Рецептурный	Рецептурный

Полные записи

Frequently asked questions

What is the difference between Icatibant and Nafarelin?: Icatibant is classified as "Исследования (прочее)", while Nafarelin is classified as "Исследования (прочее)". Icatibant: Icatibant is a synthetic decapeptide and selective antagonist of the bradykinin B2 receptor. It is approved to treat acute attacks of hereditary angioedema (HAE). Nafarelin: Nafarelin is a GnRH agonist and the only member of this class delivered as a nasal spray. It is approved for treating endometriosis and central precocious puberty. This page contrasts both neutrally and source-based — with no usage or dosing recommendation.
Which peptide is better supported by science, Icatibant or Nafarelin?: The highest available evidence level is "РКИ на людях" for Icatibant and "РКИ на людях" for Nafarelin. A higher evidence level means more robust data, but says nothing about suitability for an individual. The full body of evidence is on each peptide's own page.
What is the legal status of Icatibant and Nafarelin in Germany and the United States?: Германия: Icatibant — Рецептурный, Nafarelin — Рецептурный. США: Icatibant — Рецептурный, Nafarelin — Рецептурный. These are factual summaries with source and review date on the individual pages.

Country

Icatibant

Nafarelin

Германия

Рецептурный

США

Рецептурный

Frequently asked questions

What is the difference between Icatibant and Nafarelin?

Icatibant is classified as "Исследования (прочее)", while Nafarelin is classified as "Исследования (прочее)". Icatibant: Icatibant is a synthetic decapeptide and selective antagonist of the bradykinin B2 receptor. It is approved to treat acute attacks of hereditary angioedema (HAE). Nafarelin: Nafarelin is a GnRH agonist and the only member of this class delivered as a nasal spray. It is approved for treating endometriosis and central precocious puberty. This page contrasts both neutrally and source-based — with no usage or dosing recommendation.

Which peptide is better supported by science, Icatibant or Nafarelin?

The highest available evidence level is "РКИ на людях" for Icatibant and "РКИ на людях" for Nafarelin. A higher evidence level means more robust data, but says nothing about suitability for an individual. The full body of evidence is on each peptide's own page.

What is the legal status of Icatibant and Nafarelin in Germany and the United States?

Германия: Icatibant — Рецептурный, Nafarelin — Рецептурный. США: Icatibant — Рецептурный, Nafarelin — Рецептурный. These are factual summaries with source and review date on the individual pages.